U.S. regulator is reviewing Abbott’s fast COVID test after studies raise accuracy concerns

The U.S. Food and Drug Administration said on Thursday that Abbott Laboratories’ speedy coronavirus test, which can deliver results within minutes and is used at the White House, could potentially be inaccurate but can still be used to test patients.

…read more

Source:: Reuters – Business News